Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesZEN Graphene Solutions Ltd

ZEN Graphene Solutions Ltd

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
None USD 0.00(0%)
Last update at 2026-11-10T21:02:58.289994Z
Market Cap
112.36M

Momentum Score

…

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops graphene oxide synthesis and graphene synthesis. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.97
Low
1.75
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.03M
Revenue Per Share
-
Gross Profit TTM
-0.86M
Debt / Equity
0.05
ROE
-49.55%
Net Debt
-8.75M
ROCE
-45.84%
Diluted EPS TTM
-0.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -14.41M -12.02M -3.87M -1.54M -2.43M
Net income -14.41M -38.69M -3.87M -1.53M -2.43M
Selling general administrative 10.62M 10.25M 4.20M 1.65M 2.46M
Selling and marketing expenses 0.31M 0.28M 0.07M 0.09M 0.07M
Gross profit -0.86M -0.28M -0.13M -0.02M -0.01M
Reconciled depreciation 0.54M 0.61M 0.13M 0.02M 0.01M
Ebit -14.15M -11.96M -3.98M -1.68M -2.47M
Ebitda -13.61M -11.34M -3.86M -1.56M -2.46M
Depreciation and amortization 0.54M 0.61M 0.13M 0.12M 0.01M
Operating income -14.52M -12.56M -3.98M -1.68M -2.47M
Other operating expenses 14.73M 12.32M 3.98M 1.59M 2.47M
Interest expense 0.12M 0.06M 0.06M 0.00M 0.00M
Interest income 0.51M 0.02M 0.01M 0.01M 0.02M
Net interest income 0.38M -0.04M 0.01M 0.01M 0.02M
Income tax expense 0.12M 26.74M -0.01M -0.01M 0.04M
Total revenue 0.07M 0.34M 0.34M 0.00M 0.00M
Total operating expenses 14.73M 12.32M 3.98M 1.59M 2.47M
Cost of revenue 0.93M 0.61M 0.13M 0.02M 0.01M
Total other income expense net -0.15M 0.00M 0.11M 0.14M 0.02M
Discontinued operations - -26.67M -26.67M -26.67M -26.67M
Net income from continuing ops -14.41M -12.02M -3.87M -1.54M -2.43M
Net income applicable to common shares - -38.69M -3.87M -1.54M -2.43M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 33.29M 37.98M 30.25M 26.24M 25.54M
Other current assets 1.19M 1.01M 0.17M 0.19M 0.03M
Total liab 2.90M 3.44M 2.79M 0.53M 0.65M
Total stockholder equity 30.38M 34.55M 27.46M 25.71M 24.90M
Other current liab 1.51M 1.26M 2.01M 0.14M 0.03M
Common stock 85.75M 85.49M 43.80M 40.21M 38.31M
Capital stock 85.75M 85.49M 43.80M 40.21M 38.31M
Retained earnings -66.20M -59.18M -20.49M -16.90M -16.31M
Cash 10.36M 26.68M 3.09M 0.81M 1.22M
Total current liabilities 2.42M 2.30M 2.51M 0.53M 0.65M
Current deferred revenue -1.13M -1.10M 0.03M -0.12M -
Net debt -8.75M -24.44M -2.69M -0.81M -1.22M
Short term debt 1.13M 1.10M 0.12M 0.12M -
Short long term debt 1.00M 0.95M - - -
Short long term debt total 1.61M 2.23M 0.40M 0.40M -
Other stockholder equity -19.56M 8.23M -23.31M -23.31M -22.00M
Property plant equipment - 6.03M 26.86M 25.16M 24.08M
Total current assets 17.95M 31.96M 3.39M 1.07M 1.47M
Net tangible assets - 34.55M 27.46M 25.71M 24.90M
Net receivables 3.55M 3.61M 0.12M 0.08M 0.22M
Long term debt - 1.00M - - -
Inventory 2.85M 0.67M 0.67M - -
Accounts payable 0.91M 1.04M 0.35M 0.39M 0.62M
Accumulated other comprehensive income - - - - 1.75M
Non currrent assets other -15.34M - -26.86M -25.16M -24.08M
Non current assets total 15.34M 6.03M 26.86M 25.16M 24.08M
Capital lease obligations 0.61M 0.28M 0.40M - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -2.31M -7.25M -1.23M -1.24M -1.74M
Change to liabilities -0.02M 0.83M 0.06M -0.07M 0.55M
Total cashflows from investing activities - -7.25M -1.23M -1.24M -1.74M
Net borrowings - -0.12M -0.07M -0.07M -0.07M
Total cash from financing activities -1.05M 38.82M 5.31M 2.18M 4.05M
Change to operating activities -0.18M -0.99M 0.02M -0.16M 0.02M
Net income -14.41M -12.02M -3.87M -1.54M -2.43M
Change in cash -16.32M 23.58M 2.29M -0.42M 1.12M
Begin period cash flow 26.68M 3.09M 0.81M 1.22M 0.10M
End period cash flow 10.36M 26.68M 3.09M 0.81M 1.22M
Total cash from operating activities -12.96M -7.99M -1.79M -1.36M -1.18M
Issuance of capital stock 0.00M 35.34M 2.05M 2.26M 4.30M
Depreciation 0.54M 0.61M 0.13M 0.02M 0.01M
Other cashflows from investing activities - -0.32M 0.13M 0.37M 0.37M
Change to inventory -2.18M -0.67M -0.67M -0.67M -0.67M
Change to account receivables -0.01M -0.54M -0.04M 0.14M -0.19M
Other cashflows from financing activities 0.05M 3.60M 3.34M -0.08M -0.26M
Change to netincome - 31.45M 1.91M 0.25M 0.86M
Capital expenditures 2.27M 3.99M 0.25M 0.10M 0.00M
Change in working capital -2.40M -1.36M 0.04M -0.09M 0.38M
Stock based compensation 3.20M 4.73M 2.02M 0.29M 0.89M
Other non cash items 0.92M 0.05M -0.11M -0.04M 1.24M
Free cash flow -15.23M -11.97M -2.05M -1.46M -1.19M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ISRG
Intuitive Surgical Inc		 -
-%		 450.04 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 0.23
0.11%		 213.23 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -2.25
2.10%		 104.95 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -
-%		 212.61 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

ZEN Graphene Solutions Ltd

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops graphene oxide synthesis and graphene synthesis. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

24 Corporate Court, Guelph, ON, Canada, N1G 5G5

844-730-9822

https://www.zentek.com

29

Name Title Year Born
Dr. Francis Dube B.Sc. Exec. Chairman NA
Mr. Gregory Fenton C.F.A. CEO & Director NA
Mr. Brian Bosse B.A., C.F.A. COO & Director 1973
Ms. Wendy Ford CA, CPA Chief Financial Officer NA
Dr. Colin van der Kuur B.Sc., DMIN VP of Science & Research NA
Mr. Ryan Shacklock VP of Strategy, Bus. Devel. & Investor Relations NA
Dr. Francis Dube B.Sc. COO & Director NA
Dr. Colin van der Kuur B.Sc., DMIN Chief Science Officer NA
Mr. Ryan Shacklock Senior Vice President of Strategy & Business Development NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DRUG
CAD 32.00
+23.08%
CHR
CAD 35.50
+7.80%
HG
CAD 4.77
+7.19%
QTWO
CAD 1.73
+7.14%
PET
CAD 23.03
+7.02%
MUX
CAD 18.80
-17.69%
URE
CAD 0.96
-15.04%
WELL
CAD 3.62
-14.82%
ITH
CAD 2.01
-10.67%
SGML
CAD 7.52
-9.94%

Equity Sectors*

  • Basic Materials

    -3.56%

  • Communication Services

    +0.11%

  • Consumer Cyclical

    -0.57%

  • Consumer Defensive

    -0.30%

  • Energy

    +0.19%

  • Financial Services

    -0.06%

  • Healthcare

    -0.37%

  • Industrials

    -0.81%

  • Real Estate

    -0.85%

  • Technology

    -0.12%

  • Utilities

    -0.11%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…